Term: DTGM fusion protein Pronunciation: (... FYOO-zhun PROH-teen) May 23, 2024October 15, 2024 Description: An anticancer drug formed by the combination of diphtheria toxin and a colony-stimulating factor (GM-CSF). The colony-stimulating factor is attracted to cancer cells, and the diphtheria toxin kills the cells. Related Posts:Larotrectinib - A Novel Age and Tumor Agnostic…Larotrectinib - A Novel Age and Tumor Agnostic…FDA Approves VITRAKVI®, A Novel Tumor Agnostic…FDA Approves GAVRETO® for Metastatic RET…Early-Stage Multi-Cancer Detection Using an…p16 Protein Expression and Human Papillomavirus…